JVAIX
Price
$39.33
Change
-$0.17 (-0.43%)
Updated
Aug 15 closing price
Net Assets
8.97B
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

JVAIX vs VVIAX

Header iconJVAIX vs VVIAX Comparison
Open Charts JVAIX vs VVIAXBanner chart's image
JPMorgan Value Advantage L
Price$39.33
Change-$0.17 (-0.43%)
VolumeN/A
Net Assets8.97B
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
JVAIX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVAIX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVAIX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. JVAIX (8.97B). VVIAX pays higher dividends than JVAIX: VVIAX (2.18) vs JVAIX (1.54). JVAIX was incepted earlier than VVIAX: JVAIX (20 years) vs VVIAX (25 years). JVAIX (0.69) is less costly to investors than VVIAX (0.05). JVAIX is a more actively managed with annual turnover of: 17.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than JVAIX: VVIAX (3000) vs JVAIX (3000000). VVIAX annual gain was more profitable for investors over the last year : 7.91 vs. JVAIX (0.56). VVIAX return over 5 years is better than : 68.54 vs. JVAIX (31.35).
JVAIXVVIAXJVAIX / VVIAX
Total Expense Ratio0.690.051,380%
Annual Report Gross Expense Ratio0.690.051,380%
Fund Existence20 years25 years-
Gain YTD4.6296.51771%
Front LoadN/AN/A-
Min. Initial Investment30000003000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets8.97B196B5%
Annual Yield % from dividends1.542.1871%
Returns for 1 year0.567.917%
Returns for 3 years1.2525.935%
Returns for 5 years31.3568.5446%
Returns for 10 years44.73114.6139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp